Neutralizing IL-22 Prevents Psoriasis In Mice
Main Category: Eczema / PsoriasisAlso Included In: Biology / Biochemistry; Genetics
Article Date: 20 Jan 2008 - 7:00 PDT
| Patient / Public: | ![]() |
4.33 (3 votes) |
| Health Professional: | ![]() |
4.5 (2 votes) |
| Article Opinions: | 0 posts |
Psoriasis, which is a chronic disease characterized by the development of red, scaly, raised skin lesions, affects approximately 2% of the population of countries of the Western world. A new study by Lynette Fouser and colleagues at Wyeth Research, Cambridge, Massachusetts, has provided evidence that the soluble molecule IL-22 is central to the development of disease in a mouse model of psoriasis. Antibodies that neutralized IL-22 were found to prevent the development of psoriasis-like disease, reducing thickening of the skin, inflammatory infiltrates, and expression of Th17 cytokines. Conversely administration of IL-22 into the skin of normal mice induced the expression of genes associated with the development of psoriasis-like skin lesions. These data led the authors to suggest that antagonizing IL-22 might provide a new approach to treating individuals with psoriasis.
----------------------------
Article adapted by Medical News Today from original press release.
----------------------------
Title: IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation
Author: Lynette A. Fouser
Wyeth Research, Cambridge, Massachusetts, USA.
Source: Karen Honey
Journal of Clinical Investigation
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add to:
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2008 MediLexicon International Ltd |




